Medical Care Expenditures for Individuals with Prediabetes: The Potential Cost Savings in Reducing the Risk of Developing Diabetes.
Medical Care Expenditures for Individuals with Prediabetes: The Potential Cost Savings in Reducing the Risk of Developing Diabetes.
复制标题
DOI：
10.1089/pop.2016.0134
复制
发表时间：
2017-10
影响因子：
2.5
通讯作者：
Wozniak G
中科院分区：
文献类型：
--
作者：
Khan T;Tsipas S;Wozniak G
美国有8600万成年人患有前驱糖尿病。糖尿病前期患者可以通过改变生活方式来预防或延迟2型糖尿病的发展，例如参加国家糖尿病预防计划（DPP），从而减轻与糖尿病相关的医疗和经济负担。使用Truven Health MarketScan®实验室数据库的个人水平索赔数据对商业保险人群进行了队列分析，以识别患有前驱糖尿病的成年人，跟踪他们是否患糖尿病，并比较新诊断糖尿病的人与非糖尿病患者的医疗支出。然后，这项研究说明了如何通过参与循证生活方式改变计划来降低患糖尿病的风险，从而在医疗保健支出和投资回报率（ROI）方面产生积极的净储蓄。发现那些在随后几年中发展为糖尿病的人的年支出比那些没有从糖尿病前期转变为糖尿病的人高出近三分之一，平均每年差异为2671美元。按照该成本差异，全国DPP的3年投资回报率估计高达42%。研究结果显示了参与生活方式干预计划以预防或延迟2型糖尿病发作的重要性和经济效益。
The United States has 86 million adults with prediabetes. Individuals with prediabetes can prevent or delay the development of type 2 diabetes through lifestyle modifications such as participation in the National Diabetes Prevention Program (DPP), thereby mitigating the medical and economic burdens associated with diabetes. A cohort analysis of a commercially insured population was conducted using individual-level claims data from Truven Health MarketScan® Lab Database to identify adults with prediabetes, track whether they develop diabetes, and compare medical expenditures for those who are newly diagnosed with diabetes to those who are not. This study then illustrates how reducing the risk of developing diabetes by participation in an evidence-based lifestyle change program could yield both positive net savings on medical care expenditures and return on investment (ROI). Annual expenditures are found to be nearly one third higher for those who develop diabetes in subsequent years relative to those who do not transition from prediabetes to diabetes, with an average difference of $2671 per year. At that cost differential, the 3-year ROI for a National DPP is estimated to be as high as 42%. The results show the importance and economic benefits of participation in lifestyle intervention programs to prevent or delay the onset of type 2 diabetes.
登录
查看更多内容
影响因子：
16.2
作者：
Diabetes Prevention Program Research Group
通讯作者：
Diabetes Prevention Program Research Group
血红蛋白A1C和禁食等离子体葡萄糖定义的美国前糖尿病前期的世俗变化：国家健康和营养检查调查，1999-2010。
影响因子：
16.2
作者：
Bullard KM;Saydah SH;Imperatore G;Cowie CC;Gregg EW;Geiss LS;Cheng YJ;Rolka DB;Williams DE;Caspersen CJ
通讯作者：
Caspersen CJ
影响因子：
16.2
作者：
Chatterjee R;Narayan KM;Lipscomb J;Phillips LS
通讯作者：
Phillips LS
影响因子：
16.2
作者：
Brown, JB;Nichols, GA;Bakst, AW
通讯作者：
Bakst, AW
影响因子：
39.2
作者：
Herman, WH;Hoerger, TJ;Ratner, RE
通讯作者：
Ratner, RE